...
首页> 外文期刊>Molecular medicine reports >Knockdown of long noncoding RNA GHET1 inhibits cell-cycle progression and invasion of gastric cancer cells
【24h】

Knockdown of long noncoding RNA GHET1 inhibits cell-cycle progression and invasion of gastric cancer cells

机译:长度非编码RNA GHET1的敲低抑制细胞周期进展和胃癌细胞的侵袭

获取原文
获取原文并翻译 | 示例

摘要

GHET1 is an oncogenic long noncoding RNA (lncRNA) that promotes the proliferation and invasion of many malignant cell types. However, the function and underlying mechanisms of lncRNA GHET1 in gastric cancer are not fully understood. In this study, the expression of GHET1 was investigated in gastric cancer and it was determined whether GHET1 may potentially be used as a biomarker for the disease. The gastric cancer cell lines MGC-803 and AGS were transfected with GHET1-directed small interfering RNA (siRNA) and the changes in phenotype and cell-cycle-related molecules were assessed. The downregulation of GHET1 induced G0/G1-phase arrest in gastric cancer cells and inhibited their proliferation, migration, and invasion. DNA synthesis and the expression of proliferating cell nuclear antigen (PCNA) decreased, which was consistent with the results of the CCK-8 assay. The levels of specific cell-cycle regulators were determined and the expression and activities of positive cell-cycle regulators (cyclin D, CDK4, CDK6, cyclin E, CDK2) were reduced, whereas those of a negative regulator (P21) were increased in GHET1-knockdown cells. Taken together, the present findings show that the downregulation of GHET1 not only inhibits the migration and invasion of gastric cancer cells, but also inhibits their proliferation, at least in part by upregulating P21 expression and downregulating cyclin and CDK expression to inhibit the G0/G1 to S phase transition. The present findings may provide a potential therapeutic target for gastric cancer.
机译:GHET1是一种致癌的长度非编码RNA(LNCRNA),可促进许多恶性细胞类型的增殖和侵袭。然而,胃癌中LNCRNA GHET1的功能和潜在机制尚不完全理解。在这项研究中,在胃癌中研究了GHET1的表达,确定GHET1是否可能被用作疾病的生物标志物。用GHET1定向的小干扰RNA(siRNA)转染胃癌细胞系MGC-803和AG,评估表型和细胞循环相关分子的变化。 GHET1的下调诱导胃癌细胞中G0 / G1相捕获,​​抑制其增殖,迁移和侵袭。 DNA合成和增殖细胞核抗原(PCNA)的表达降低,这与CCK-8测定结果一致。确定特异性细胞周期调节剂的水平,并降低了阳性细胞周期调节剂(Cyclin D,CDK4,CDK6,Cyclin E,CDK2)的表达和活性,而阴性调节剂(P21)的表达和较多-knockdown细胞。本研究结果表明,GHET1的下调不仅抑制胃癌细胞的迁移和侵袭,还抑制它们的增殖,而且至少部分地通过上调P21表达和下调的细胞周期蛋白和CDK表达来抑制G0 / G1到S相转变。本发现可以为胃癌提供潜在的治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号